1. Home
  2. CMI vs REGN Comparison

CMI vs REGN Comparison

Compare CMI & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cummins Inc.

CMI

Cummins Inc.

HOLD

Current Price

$533.86

Market Cap

81.7B

Sector

Industrials

ML Signal

HOLD

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$778.61

Market Cap

68.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMI
REGN
Founded
1919
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.7B
68.8B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
CMI
REGN
Price
$533.86
$778.61
Analyst Decision
Buy
Buy
Analyst Count
14
25
Target Price
$587.69
$830.16
AVG Volume (30 Days)
888.7K
530.7K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
1.25%
0.55%
EPS Growth
N/A
8.19
EPS
11.44
18.95
Revenue
$33,670,000,000.00
$5,872,227,000.00
Revenue This Year
$7.23
$12.45
Revenue Next Year
$8.58
$10.13
P/E Ratio
$48.12
$41.24
Revenue Growth
N/A
20.82
52 Week Low
$400.72
$541.00
52 Week High
$737.76
$859.34

Technical Indicators

Market Signals
Indicator
CMI
REGN
Relative Strength Index (RSI) 25.66 47.54
Support Level $527.76 $779.08
Resistance Level $611.51 $818.06
Average True Range (ATR) 12.25 17.98
MACD -0.38 -9.44
Stochastic Oscillator 8.84 9.69

Price Performance

Historical Comparison
CMI
REGN

About CMI Cummins Inc.

Cummins is a leading manufacturer of diesel and other engines used in heavy- and medium-duty commercial trucks, off-highway equipment, and locomotives, in addition to prime power and standby generators. The company also sells powertrain components, which include filtration products, transmissions, turbochargers, aftertreatment systems, and fuel systems. Sales are approximately 60% US and Canada and 40% rest of the world. Much of Cummins' foreign sales (China, India, and so forth) are through joint ventures. The company operates 650 distributors and over 19,000 dealer locations across 190 countries. Cummins' business model is unique as it competes with many of its heavy-duty truck manufacturer customers, which also make their own engines.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: